We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Clearance System Removes Mucus from the Airways

By HospiMedica International staff writers
Posted on 16 Jan 2014
A new lung drainage system uses high frequency chest wall oscillations (HFCWO) to clear mucus in the airways.

The SmartVest SQL HFCWO system is intended for patients with long- term pulmonary issues such as bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis, muscular dystrophy, and cerebral palsy, or for treating chest congestion associated with more than 400 different medical conditions including neuromuscular and immune disorders. More...
HFCWO systems are often the last option available when chest congestion cannot be cleared by more conventional therapies such as drugs, chest physical therapy, special coughing techniques, or cough-assist aids.

The SQL system consists of a wearable vest with an inflatable air bladder that is connected by a hose to a programmable air compressor that delivers air into bladder in repetitive cycles, thus creating a squeezing cycle action on the upper body torso. The squeezing action serves as a “mini-cough,” helping to dislodge stubborn mucus from the airways and reducing the thickness of the mucus to help it propel towards larger airways.

The system boasts a lightweight soft-fabric vest, a smaller, quieter, and lighter generator than previous versions, enhanced ramping, an enhanced pause feature, and a user-friendly graphic interface. The system is intended for use twice daily for 15–30 minutes, with the air compressor programmed to deliver 5 to 20 compressions per second. The SmartVest SQL HFCWO system is a product of Electromed (New Prague, MN, USA), and has been approved by the US Food and Drug Administration (FDA).

“We designed the SQL to stand apart from the competition with features that our patients and clinicians were asking for. They talked, and we listened,” said Kathleen Skarvan, CEO of Electromed.

Related Links:

Electromed



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
OR Table Accessory
Angular Accessory Rail
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.